(Q53813254)

20 May 2018

title

Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease. (English)

1 reference

20 May 2018

metabolic dysfunction–associated steatotic liver disease

1 reference

1 reference

1

1 reference

20 May 2018

Federico Salomone

4

1 reference

20 May 2018

Gian Paolo Caviglia

12

1 reference

20 May 2018

Amalia Gastaldelli

17

1 reference

20 May 2018

Ramy Younes

Ramy Younes

9

0 references

Chiara Saponaro

Chiara Saponaro

10

0 references

Melania Gaggini

Melania Gaggini

3

0 references

Elisabetta Bugianesi

18

Elisabetta Bugianesi

1 reference

20 May 2018

14

Antonina Smedile

1 reference

20 May 2018

Mario Rizzetto

15

Mario Rizzetto

1 reference

20 May 2018

author name string

Lavinia Mezzabotta

2

1 reference

20 May 2018

Roberto Gambino

5

1 reference

20 May 2018

Andrea Marengo

6

1 reference

20 May 2018

Francesca Saba

7

1 reference

20 May 2018

Ester Vanni

8

1 reference

20 May 2018

Emma Buzzigoli

11

1 reference

20 May 2018

Maria Lorena Abate

13

1 reference

20 May 2018

Maurizio Cassader

16

1 reference

20 May 2018

language of work or name

English

0 references

publication date

8 December 2015

1 reference

20 May 2018

published in

Hepatology

1 reference

20 May 2018

volume

63

1 reference

20 May 2018

issue

1

1 reference

20 May 2018

page(s)

107-116

1 reference

20 May 2018

Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research

cites work

1 reference

7 January 2021

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

1 reference

7 January 2021

Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace

1 reference

7 January 2021

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

1 reference

7 January 2021

Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

1 reference

7 January 2021

The epidemiology of obesity

1 reference

7 January 2021

High body mass index for age among US children and adolescents, 2003-2006

1 reference

7 January 2021

Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches

1 reference

7 January 2021

Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012.

1 reference

7 January 2021

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

1 reference

7 January 2021

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

1 reference

7 January 2021

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

1 reference

7 January 2021

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

1 reference

7 January 2021

Use and abuse of HOMA modeling

1 reference

7 January 2021

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

7 January 2021

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

1 reference

7 January 2021

Measuring and estimating insulin resistance in clinical and research settings

1 reference

7 January 2021

Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease

1 reference

7 January 2021

Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis

1 reference

7 January 2021

Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease

1 reference

7 January 2021

Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism.

1 reference

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

7 January 2021

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

1 reference

7 January 2021

A simple measure of insulin resistance

1 reference

7 January 2021

Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies.

1 reference

7 January 2021

Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests. The Insulin Resistance Atherosclerosis Study.

1 reference

7 January 2021

Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance?

1 reference

7 January 2021

A model-based method for assessing insulin sensitivity from the oral glucose tolerance test

1 reference

7 January 2021

Relationship between the hyperinsulinemic-euglycaemic clamp and a new simple index assessing insulin sensitivity in overweight and obese postmenopausal women.

1 reference

7 January 2021

Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.

1 reference

7 January 2021

Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test.

1 reference

7 January 2021

A novel surrogate index for hepatic insulin resistance.

1 reference

7 January 2021

The BIGTT test: a novel test for simultaneous measurement of pancreatic beta-cell function, insulin sensitivity, and glucose tolerance.

1 reference

7 January 2021

Pioglitazone improvement of fasting and postprandial hyperglycaemia in Mexican-American patients with Type 2 diabetes: a double tracer OGTT study

1 reference

7 January 2021

Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease

1 reference

7 January 2021

Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease

1 reference

7 January 2021

Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes.

1 reference

7 January 2021

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

1 reference

7 January 2021

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

7 January 2021

Comparative evaluation of whole body and hepatic insulin resistance using indices from oral glucose tolerance test in morbidly obese subjects with nonalcoholic Fatty liver disease

1 reference

7 January 2021

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

1 reference

7 January 2021

Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms

1 reference

7 January 2021

The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome

1 reference

7 January 2021

Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.

1 reference

7 January 2021

Dietary fructose exacerbates hepatocellular injury when incorporated into a methionine-choline-deficient diet

1 reference

7 January 2021

Differing endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance.

1 reference

7 January 2021

Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).

1 reference

7 January 2021

Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.

1 reference

7 January 2021

Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.28287

1 reference

20 May 2018

1 reference

20 May 2018